Off-label use refers to the practice of prescribing a medication for a purpose other than its approved indication. While GLP-1 receptor agonists like Wegovy have been primarily approved for the treatment of diabetes and chronic weight management, there has been growing interest in their off-label use for other conditions.
Off-label use refers to the practice of prescribing a medication for a purpose other than its approved indication. While GLP-1 receptor agonists like Wegovy have been primarily approved for the treatment of diabetes and chronic weight management, there has been growing interest in their off-label use for other conditions.
Off-label use refers to the practice of prescribing a medication for a purpose other than its approved indication. While GLP-1 receptor agonists like Wegovy have been primarily approved for the treatment of diabetes and chronic weight management, there has been growing interest in their off-label use for other conditions.
